James E Hoffman

Assistant Professor of Clinical

  • 247 Citations
20082018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where James E Hoffman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Amyloidosis Medicine & Life Sciences
Light Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Immunoglobulin M Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Extranodal NK-T-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

  • 247 Citations
  • 12 Article
34 Citations (Scopus)

Selective inhibition of nuclear export with oral selinexor for treatment of relapsed or refractory multiple myeloma

Vogl, D. T., Dingli, D., Cornell, R. F., Huff, C. A., Jagannath, S., Bhutani, D., Zonder, J., Baz, R., Nooka, A., Richter, J., Cole, C., Vij, R., Jakubowiak, A., Abonour, R., Schiller, G., Parker, T. L., Costa, L. J., Kaminetzky, D., Hoffman, J. E., Yee, A. J. & 12 others, Chari, A., Siegel, D., Fonseca, R., Van Wier, S., Ahmann, G., Lopez, I., Kauffman, M., Shacham, S., Saint-Martin, J. R., Picklesimer, C. D., Choe-Juliak, C. & Keith Stewart, A., Jan 1 2018, In : Journal of Clinical Oncology. 36, 9, p. 859-866 8 p.

Research output: Contribution to journalArticle

Cell Nucleus Active Transport
Multiple Myeloma
Rubiaceae
Therapeutics
Dexamethasone
1 Citation (Scopus)

Severe mononeuritis multiplex after rituximab in IgM-κ monoclonal gammopathy

Lizarraga, A., Lizarraga, K. J., Hoffman, J. E., Ascherman, D., Shebert, R. T. & Verma, A., Jan 1 2017, (Accepted/In press) In : Muscle and Nerve.

Research output: Contribution to journalArticle

Mononeuropathies
Cryoglobulins
Paraproteinemias
Antigen-Antibody Complex
Immunoglobulin M
4 Citations (Scopus)
Myelin-Associated Glycoprotein
Waldenstrom Macroglobulinemia
Peripheral Nervous System Diseases
Immunoglobulin M
Antibodies
6 Citations (Scopus)

Phase II study of <sup>90</sup>Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma

Lossos, I., Fabregas, J. C., Sengul, T., Miao, F., Goodman, D., Serafini, A. N., Hosein, P., Stefanovic, A., Rosenblatt, J. D. & Hoffman, J. E., Jun 1 2015, In : Leukemia and Lymphoma. 56, 6, p. 1750-1755 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Lymphoma
Confidence Intervals
Radioimmunotherapy
Survival
3 Citations (Scopus)

Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma

Hosein, P., Sandoval-Sus, J. D., Goodman, D., Arteaga, A. G., Reis, I., Hoffman, J. E., Stefanovic, A., Rosenblatt, J. D. & Lossos, I., Jun 1 2015, In : American Journal of Hematology. 90, 6, p. E111-E116

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Survival Analysis
Maintenance
Thalidomide
Drug Therapy